RAPT Therapeutics, Inc. (RAPT) Tops Q3 EPS by 9c

RAPT Therapeutics, Inc. (NASDAQ: RAPT) reported Q3 EPS of ($0.47), $0.09 better than the analyst estimate of ($0.56).

For earnings history and earnings-related data on RAPT Therapeutics, Inc. (RAPT) click here.

You May Also Be Interested In

• S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
• S&P announces major changes in S&P 100, S&P 500, S&P 400
• General Dynamics wins $249m in US military contracts